STOCK TITAN

LifeVantage Announces Expansion of its European Footprint with Market Opening in Portugal

LifeVantage (Nasdaq: LFVN) will expand into Portugal with a planned May 2026 launch, offering flagship nutrigenomic products nationwide and introducing its independent Consultant business opportunity.

(Positive)
Tags

LifeVantage (Nasdaq: LFVN) will expand into Portugal with a planned May 2026 launch, offering flagship nutrigenomic products nationwide and introducing its independent Consultant business opportunity.

Initial portfolio includes Protandim Nrf2, Protandim Nrf1, and TrueScience Liquid Collagen; enrollment inquiries directed to ptsupport@lifevantage.com.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.
Argus Apr 2 session
+1.19% close to close Open Argus
Details

News Market Reaction – LFVN

On Apr 2, the day this news came out, LFVN closed 1.19% above the previous close.

Data tracked by StockTitan Argus for the Apr 2 session.

Market Context

This announcement highlights LifeVantage’s strategy of broadening its international footprint by ope...
Analysis

This announcement highlights LifeVantage’s strategy of broadening its international footprint by opening the Portugal market in May 2026 with flagship Protandim and TrueScience products and its Consultant model. It follows a period of mixed signals, including weaker Q2 FY26 results and CEO succession planning. Investors may watch how quickly Portugal contributes to growth, any follow-on product introductions, and how expansion intersects with the company’s effective $75.0 million shelf capacity.

Key Figures

Portugal launch timing: May 2026 Announcement date: April 02, 2026
Portugal launch timing
May 2026
Planned market opening date for Portugal expansion
Announcement date
April 02, 2026
Date of Portugal market expansion press release

Historical Context

5 past events · Latest: Mar 16
5 events
  1. Mar 16

    Conference participation

    24h Move
    +0.8%

    Participation in Sidoti Small Cap Conference with virtual investor meetings.

  2. Feb 04

    Dividend declaration

    24h Move
    -16.8%

    Board declared a $0.045 per-share quarterly cash dividend.

  3. Feb 04

    CEO retirement plan

    24h Move
    -16.8%

    Announcement of CEO Steve Fife’s planned retirement and succession search.

  4. Feb 04

    Earnings release

    24h Move
    -16.8%

    Q2 FY26 results with revenue down 27.8% YoY but new buyback and dividend.

  5. Jan 21

    Earnings date set

    24h Move
    +4.7%

    Scheduling of Q2 FY26 results release and investor conference call.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

nutrigenomic, mitochondrial
2 terms
nutrigenomic medical
"introduces flagship nutrigenomic products and entrepreneurial opportunity to the Portuguese"
Nutrigenomic describes the study and application of how a person’s genes affect their response to foods and nutrients, and how diet can influence gene activity. Think of it as tailoring a recipe to someone’s DNA so nutrition and supplements can be more effective for that individual. Investors watch nutrigenomics because it can create premium, personalized products and services, but also brings higher research costs, regulatory scrutiny and data-privacy considerations that affect commercial value.
mitochondrial medical
"Nrf1 Synergizer – designed to support cellular energy production and healthy mitochondrial function."
Relating to mitochondria, the tiny structures inside cells that act like power plants to produce the energy cells need and help control cell survival. For investors this matters because problems with mitochondrial function are linked to certain diseases and are a focus for drugs, diagnostics and safety testing, so claims about “mitochondrial” effects can signal potential market opportunities or risks for healthcare-related companies.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Activation-focused wellness company introduces flagship nutrigenomic products and entrepreneurial opportunity to the Portuguese market

SALT LAKE CITY, April 02, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, announced today it will be expanding its products and business opportunity in Portugal, welcoming a new wave of purpose-driven entrepreneurs and wellness seekers to its growing international community. This expansion, planned for a May 2026 launch, marks the Company’s continued partnership with its field leadership on international expansion and reinforces its commitment to delivering science-backed wellness solutions to consumers around the world. The Portugal market will open with a focused portfolio of LifeVantage’s flagship products, available nationwide:

  • Protandim® Nrf2 Synergizer – formulated to support the body’s natural antioxidant response and overall cellular health.
  • Protandim® Nrf1 Synergizer – designed to support cellular energy production and healthy mitochondrial function.
  • TrueScience® Liquid Collagen – developed to support skin hydration and elasticity as part of a daily beauty-from-within routine.

In addition to individual products, customers and Consultants in Portugal will have access to curated product combinations designed to simplify wellness routines and complement a balanced diet and healthy lifestyle.

The Company plans to introduce additional products into the Portugal market over time.

Alongside its product launch, LifeVantage is introducing its independent Consultant business model in Portugal, supported by the company’s Evolve Compensation Plan, offering individuals the opportunity to build a business by sharing LifeVantage products directly with customers. Earnings are based on product sales and individual business performance. Interested individuals can prepare to enroll for the launch by sending an inquiry to ptsupport@lifevantage.com.

“Opening Portugal reflects our commitment to driving international growth, a key element of our overall growth strategy,” said Steve Fife, President and CEO of LifeVantage. “We look forward to supporting our European Consultant leaders and bringing our science-based product philosophy to this vibrant market. Portugal's entrepreneurial spirit and focus on health and wellness make it an ideal fit for our Consultants to build thriving businesses while helping others achieve their wellness goals.”

This announcement underscores LifeVantage’s broader strategy to grow its international footprint and deliver high-impact wellness solutions to an expanding global customer base.

For more information about LifeVantage, visit www.LifeVantage.com.

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work with your unique biology and help your body make what it needs for health. The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, MindBody GLP-1 System™, and the comprehensive gut activator, P84, and activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System®, as well as AXIO® nootropic energy drink mixes, the full TrueScience® line of skin and hair care products, and Petandim®, a pet supplement formulated to combat oxidative stress in dogs. Our independent Consultants sell our products to Customers and share the business opportunity with entrepreneurs seeking to begin their own business. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.

Investor Relations Contact:
Reed Anderson, ICR
(646) 277-1260
reed.anderson@icrinc.com


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will LifeVantage (LFVN) officially launch in Portugal?

LifeVantage plans a May 2026 market opening in Portugal. According to the company, the launch will roll out its initial product portfolio nationwide and enable Consultant enrollments ahead of the launch date via the provided support email.

Which LifeVantage products (LFVN) will be available at the May 2026 Portugal launch?

The Portugal launch will feature Protandim Nrf2, Protandim Nrf1, and TrueScience Liquid Collagen. According to the company, these flagship nutrigenomic items will be available individually and as curated stacks for simplified wellness routines.

What does LifeVantage's Evolve Compensation Plan mean for potential Consultants in Portugal (LFVN)?

The Evolve Compensation Plan will allow Portuguese Consultants to earn based on product sales and personal business performance. According to the company, this independent model offers individuals an opportunity to build a direct-selling business sharing LifeVantage products locally.

How can interested individuals sign up or learn more about LifeVantage (LFVN) in Portugal?

Prospective Consultants and customers can send inquiries to ptsupport@lifevantage.com to prepare for enrollment. According to the company, this contact will support registrations and provide launch information ahead of the May 2026 market opening.

Will LifeVantage (LFVN) add more products to the Portugal market after launch?

Yes, the company plans to introduce additional products in Portugal over time. According to the company, the initial rollout focuses on flagship items while the product portfolio will expand post-launch to meet local demand.

Keep reading